These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 3469466

  • 1. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW, Powell TJ, Walia AS, Lidin BI, Srinivas RV, Baskin JG, Kearney JF.
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [Abstract] [Full Text] [Related]

  • 2. Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen.
    Powell TJ, Spann R, Vakil M, Kearney JF, Lamon EW.
    J Immunol; 1988 May 01; 140(9):3266-72. PubMed ID: 3258895
    [Abstract] [Full Text] [Related]

  • 3. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ, Spann R, Nguyenduc M, Lamon EW.
    J Immunol; 1989 Feb 15; 142(4):1318-24. PubMed ID: 2536772
    [Abstract] [Full Text] [Related]

  • 4. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL.
    J Natl Cancer Inst; 1983 Mar 15; 70(3):493-7. PubMed ID: 6572738
    [Abstract] [Full Text] [Related]

  • 5. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V, Lahaye T, Horvath C, Zanovello P, Collavo D, Engers HD.
    Eur J Immunol; 1987 Feb 15; 17(2):173-8. PubMed ID: 3030766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors affecting passive monoclonal antibody therapy of Moloney sarcoma in BALB/c mice.
    Kennel SJ, Lankford PK, Flynn KM, Winegar R.
    Cancer Res; 1985 Aug 15; 45(8):3782-9. PubMed ID: 2410101
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV).
    Rosato A, Mandruzzato S, Bronte V, Zambon A, Macino B, Calderazzo F, Zanovello P, Collavo D.
    Int J Cancer; 1995 May 04; 61(3):355-62. PubMed ID: 7729948
    [Abstract] [Full Text] [Related]

  • 16. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan 04; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 17. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep 04; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.